Skip to main content

Table 2 Relative prevalence of uropathogens in non-repeated urinary samples from individual dogs

From: Characterisation of bacterial growth and antimicrobial susceptibility patterns in canine urinary tract infections

Submission category A referral hospitals 45%, (n = 284) E.coli S. pseudo-intermedius Proteus mirabilis β-haemolytic Streptococcus spp. S. aureus Enterococcus spp. Klebsiella spp.
Pre-incubated 87%, (n = 248)        
Pure growth, (n = 174) 72 (131) 57 (16) 77 (10) 78 (7) 57 (4) 71 (5) 33 (1)
Contaminated growth, (n = 74) 28 (50) 43 (12) 23 (3) 22 (2) 43 (3) 29 (2) 67 (2)
Non-incubated, 13% (n = 36)        
Pure growth, (n = 22) 74 (17) 50 (2) 25 (1) 50 (2) - 0 (0) -
Contaminated growth, (n = 14) 26 (6) 50 (2) 75 (3) 50 (2) - 100 (1) -
Submission category B small animal clinics
25%, (n = 154)
E.coli S. pseudo-intermedius Proteus mirabilis β-haemolytic Streptococcus spp. S. aureus Enterococcus spp. Klebsiella spp.
Pre-incubated, 56%, (n = 87)        
Pure growth, (n = 53) 68 (42) 67 (6) 33 (3) 0 (0) 0 (0) 100 (2) 0 (0)
Contaminated growth, (n = 34) 32 (20) 33 (3) 67 (6) 100 (2) 100 (1) 0 (0) 100 (2)
Non-incubated, 44%, (n = 67)        
Pure growth, (n = 34) 52 (25) 67 (2) 75 (6) 0 (0) - 33 (1) -
Contaminated growth, (n = 33) 48 (23) 33 (1) 25 (2) 100 (5) - 67 (2) -
Submission category C mixed veterinary practices
30%, (n =185)
E.coli S. pseudo-intermedius Proteus mirabilis β-haemolytic Streptococcus spp. S. aureus Enterococcus spp. Klebsiella spp.
Pre-incubated, 48%, (n = 88)        
Pure growth, (n = 45) 52 (29) 50 (6) 67 (6) 25 (1) 100 (2) 33 (1) 0 (0)
Contaminated growth, (n = 43) 48 (27) 50 (6) 33 (3) 75 (3) 0 (0) 67 (2) 100 (2)
Non-incubated, 52%, (n = 97)        
Pure growth, (n = 47) 51 (30) 50 (2) 50 (6) 36 (4) - 43 (3) 50 (2)
Contaminated growth, (n = 50) 49 (29) 50 (2) 50 (6) 64 (7) - 57 (4) 50 (2)
Total 68 (429) 10 (60) 9 (55) 5 (35) 2 (10) 4 (23) 2 (11)